Multiple sclerosis diagnostic delay and its associated factors in Upper Egyptian patients
- PMID: 36754987
- PMCID: PMC9908930
- DOI: 10.1038/s41598-023-28864-x
Multiple sclerosis diagnostic delay and its associated factors in Upper Egyptian patients
Abstract
The earlier the diagnosis of multiple sclerosis (MS), the sooner disease-modifying treatments can be initiated. However, significant delays still occur in developing countries. We aimed to identify factors leading to delayed diagnosis of MS in Upper Egypt. One hundred forty-two patients with remitting relapsing MS (RRMS) were recruited from 3 MS units in Upper Egypt. Detailed demographic and clinical data were collected. Neurological examination and assessment of the Disability Status Scale (EDSS) were performed. The mean age was 33.52 ± 8.96 years with 72.5% of patients were females. The mean time from symptom onset to diagnosis was 18.63 ± 27.87 months and the median was 3 months. Seventy-two patients (50.7%) achieved diagnosis within three months after the first presenting symptom (early diagnosis), while seventy patients (49.3%) had more than three months delay in diagnosis (delayed diagnosis). Patients with a delayed diagnosis frequently presented in the period before 2019 and had a significantly higher rate of initial non-motor presentation, initial non-neurological consultations, prior misdiagnoses, and a higher relapse rate. Another possible factor was delayed MRI acquisition following the initial presentation in sixty-six (46.5%) patients. Multivariable logistic regression analysis demonstrated that earlier presentation, initial non-neurological consultation, and prior misdiagnosis were independent predictors of diagnostic delay. Despite advances in MS management in Egypt, initial non-neurological consultation and previous misdiagnoses are significant factors responsible for delayed diagnosis in Upper Egypt.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
Clinical characteristics of patients with multiple sclerosis enrolled in a new registry in Egypt.Mult Scler Relat Disord. 2016 Nov;10:30-35. doi: 10.1016/j.msard.2016.06.013. Epub 2016 Jun 27. Mult Scler Relat Disord. 2016. PMID: 27919495
-
Mitoxantrone: a review of its use in multiple sclerosis.CNS Drugs. 2004;18(6):379-96. doi: 10.2165/00023210-200418060-00010. CNS Drugs. 2004. PMID: 15089110 Review.
-
Treatment satisfaction with disease-modifying therapy is the only predictor of Adherence among multiple sclerosis patients from Upper Egypt.Sci Rep. 2024 Mar 25;14(1):7027. doi: 10.1038/s41598-024-57116-9. Sci Rep. 2024. PMID: 38528018 Free PMC article.
-
Mitoxantrone in relapsing-remitting and rapidly progressive multiple sclerosis: Ten-year clinical outcomes post-treatment with mitoxantrone.Mult Scler Relat Disord. 2020 Sep;44:102330. doi: 10.1016/j.msard.2020.102330. Epub 2020 Jun 23. Mult Scler Relat Disord. 2020. PMID: 32599468
-
Approaches and challenges in the diagnosis and management of secondary progressive multiple sclerosis: A Central Eastern European perspective from healthcare professionals.Mult Scler Relat Disord. 2021 May;50:102778. doi: 10.1016/j.msard.2021.102778. Epub 2021 Jan 28. Mult Scler Relat Disord. 2021. PMID: 33592384 Review.
Cited by
-
Clinical and epidemiological characteristics of multiple sclerosis in the southern region of the Republic of Azerbaijan.Pak J Med Sci. 2025 Feb;41(2):437-442. doi: 10.12669/pjms.41.2.11373. Pak J Med Sci. 2025. PMID: 39926687 Free PMC article.
-
The Clinical Nurse Practitioner's Essential Role in Early Diagnosis and Management of Multiple Sclerosis in Europe: A Consensus Report.Int J MS Care. 2024 Aug 5;26(Q3):208-213. doi: 10.7224/1537-2073.2023-070. eCollection 2024 May. Int J MS Care. 2024. PMID: 39105046 Free PMC article.
-
A multicenter pilot study evaluating simplified central vein assessment for the diagnosis of multiple sclerosis.Mult Scler. 2024 Jan;30(1):25-34. doi: 10.1177/13524585231214360. Epub 2023 Dec 13. Mult Scler. 2024. PMID: 38088067 Free PMC article.
-
Diagnostic delay of multiple sclerosis: prevalence, determinants and consequences.Mult Scler. 2023 Oct;29(11-12):1437-1451. doi: 10.1177/13524585231197076. Mult Scler. 2023. PMID: 37840276 Free PMC article.
-
Current Practices, Challenges, and Future Directions in Multiple Sclerosis Management in Sub-Saharan Africa.Int J MS Care. 2025 Apr 15;27(Theme):T13-T16. doi: 10.7224/1537-2073.2024-080. eCollection 2024 Dec. Int J MS Care. 2025. PMID: 40241912 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical